RESUMEN
This paper deals with interaction between a bubble and fluid around it, visualized by a moving object flow image analyzer (MOFIA) consisting of a three-dimensional (3D) moving object image analyzer (MOIA) and two-dimensional particle image velocimetry (PIV). The experiments were carried out for rising bubbles of various sizes and shapes in stagnant water in a vertical pipe. In the MOFIA employed, 3D-MOIA was used to measure bubble motion and PIV to measure fluid flow. The 3D position and shape of a bubble and the velocity field were measured simultaneously. The experimental results showed that the interaction was characterized by the shape, size and density of a bubble. Concretely, they showed the characteristics of bubble motion, wake shedding, and flow field.
RESUMEN
A method for the determination of total phenylephrine (free plus conjugated) in human serum was developed using column-switching high-performance liquid chromatography (HPLC) with fluorescence detection. After serum was deproteinized with acetonitrile, the conjugated phenylephrine was hydrolyzed with diluted hydrochloric acid. The solution was evaporated to dryness. The reconstituted residue was analyzed with HPLC using a heart-cut technique. Good recoveries of the analytes from spiked human serum samples were obtained with small coefficients of variation. A good linear response was obtained for the concentration range 5-500 ng/ml. The lower limit of quantitation for phenylephrine in human serum was 5 ng/ml. The method was applied to the determination of phenylephrine in human serum after oral administration of phenylephrine hydrochloride.
Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Fenilefrina/sangre , Fluorescencia , Humanos , Hidrólisis , Fenilefrina/metabolismoRESUMEN
A method for the simultaneous determination of de(N-methyl)-N-ethyl-8,9 -anhydroerythromycin A 6,9-hemiacetal (EM523, I) and its three metabolites in human plasma and urine has been developed using high-performance liquid chromatography (HPLC) with chemiluminescence (CL) detection. Plasma and urine samples spiked with erythromycin as an internal standard were extracted with a mixture of dichloromethane and diethyl ether under alkaline conditions. The organic layer was evaporated under a stream of nitrogen gas. The reconstituted sample was injected into an HPLC apparatus and separated on an ODS column using a gradient elution method. The eluate was reacted on-line with a mixture of tris(2,2'-bipyridine) ruthenium(II) and peroxodisulfate, and the generated CL intensity was detected. Optimization of the CL reaction conditions resulted in a sensitive and stable CL intensity for the determination of I and its metabolites. The recovery of each compound from human plasma and urine, and the sensitivity, linearity, accuracy and precision of the method were satisfactory. The lower limits of quantitation for each compound using 0.2 ml of plasma and 0.1 ml of urine were 1 and 10 ng/ml, respectively. This method has been used for the determination of 1 in samples from clinical trials.
Asunto(s)
2,2'-Dipiridil/análogos & derivados , Eritromicina/análogos & derivados , Fármacos Gastrointestinales/sangre , Compuestos Organometálicos , Cromatografía Líquida de Alta Presión , Eritromicina/sangre , Eritromicina/metabolismo , Eritromicina/orina , Fármacos Gastrointestinales/metabolismo , Fármacos Gastrointestinales/orina , Humanos , Mediciones Luminiscentes , Sensibilidad y EspecificidadRESUMEN
A sensitive method for the determination of chlorpheniramine in human serum was developed using column-switching high-performance liquid chromatography (HPLC) with ultraviolet detection at 210 nm. The analyte was extracted with diethyl ether from alkalinized serum. After evaporation of the organic layer, the reconstituted residue was analyzed by HPLC using a heart-cut technique. Good recoveries of the analyte from spiked human serum samples were obtained with a coefficient of variation below 7%. A good linear response was obtained for the concentration range 0.5-50 ng/ml, with a correlation coefficient higher than 0.999. The lower limit of quantitation for chlorpheniramine in human serum was 0.5 ng/ml. The method was satisfactorily applied to the determination of chlorpheniramine in human serum after oral administration of chlorpheniramine maleate.